Reach Us +1-947-333-4405


Editor - Adel El-Naggar | University of Texas | 4911
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Google scholar citation report
Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Adel El-Naggar

Adel El-Naggar
Adel El-Naggar
Department of pathology
University of Texas
University of Texas


Dr. El-Naggar is an internationally renowned head and neck pathologist with 20 years experience in this field. He contributed extensively to the histopathology, clinicopathologic, flow cytometric, and molecular diagnostics of head and neck tumors with over 400 peer-reviewed publications. He has made a significant contribution integrating molecular and biological markers in the diagnosis and management of head and neck cancer. One of his major contributions was in 1990 with the establishment of the first comprehensive tissue acquisition programs in the nation. Through genomic analysis, his group has, for the first time, identified a set of genes that distinguishes conventional squamous carcinoma from other phenotypic squamous carcinoma variants. He was the first to identify loss of imprinting at the IGF-2 gene in head and neck squamous cell carcinoma, and the t(11:19) translocation as a sole cytogenetic alteration in mucoepidermoid carcinoma of salivary gland.

Research Interest

Molecular genetic characterization of salivary glands, mucosal and thyroid tumors and the identification and validation of biomarkers in head and neck tumorigenesis.



Global Speakers in the subject

Global Experts in the subject